Philip Ashman

Philip Ashman currently serves as President of International Operations at ANI Pharmaceuticals, Inc., a position held since September 2024. Prior to this role, Philip led international operations for Alimera Sciences from January 2013 to September 2024, where responsibilities included overseeing operations outside the United States. Philip has extensive experience in the pharmaceutical industry, including significant leadership roles at Bayer plc, where responsibilities ranged from Market Access to overseeing the Global Launch Team for Oncology, and AstraZeneca, focusing on specialist care marketing. Philip began their career at Warner Lambert and Schering-Plough Pharmaceuticals, accumulating a diverse range of experiences in clinical research and product management. Philip holds a PhD in Biochemistry from Royal Holloway, University of London, and a BSc in Biochemistry from UCL.